1. Goldberg RJ, Yarzebski J., Lessard D., Wu J., Gore J.M. Recent trends in the incidence rates of and death rates from atrial fibrillation complicating initial acute myocardial infarction: A community-wide perspective. American Heart Journal. 2002,143 (3):519-27. DOI:10.1067/mhj. 2002.120410

2. Rathore SS, Berger AK, Weinfurt KP, Schulman О.Д., Oetgen WJ, Gersh BJ et al. Acute myocardial infarction complicated by atrial fibrillation in the elderly: prevalence and outcomes. Circulation. 2000,101 (9):969-74. PMID :10704162

3. Crenshaw BS, Ward SR, Granger CB, Stebbins AL, Topol EJ, Califf R.M. Atrial Fibrillation in the Setting of Acute Myocardial Infarction: The GUSTO-I Experience fn1fn1This study was funded by grants from Genentech, South San Francisco, California, Bayer Corporation, New York, New York, CIBA-Corning, Medfield, Massachusetts, ICI Pharmaceuticals, Wilmington, Delaware, and Sanofi Pharmaceuticals, Paris, France. Journal of the American College of Cardiology. 1997,30 (2):406-13. DOI:10.1016/S0735-1097 (97) 00194-0

4. Wong CK, White HD, Wilcox RG, Criger DA, Califf RM, Topol EJ et al. New atrial fibrillation after acute myocardial infarction independently predicts death: the GUSTO-III experience. Am Heart J. 2000,140 (6):878-85. PMID:11099991

5. Stenestrand U. Anticoagulation Therapy in Atrial Fibrillation in Combination With Acute Myocardial Infarction Influences Long-Term Outcome: A Prospective Cohort Study From the Register of Information and Knowledge About Swedish Heart Intensive Care Admissions (RIKS-HIA). Circulation. 2005,112 (21):3225-31. DOI: 10.1161 /CIRCULATIONAHA. 105.552984

6. Lopes RD, Pieper KS, Horton JR, Al-Khatib SM, Newby LK, Mehta RH et al. Short- and long-term outcomes following atrial fibrillation in patients with acute coronary syndromes with or without ST-segment elevation. Heart. 2008,94 (7):867-73. DOI:10.1136 /hrt. 2007.134486

7. Gonzalez-Pacheco H., Marquez MF, Arias-Mendoza A., Alvarez-Sangabriel A., Eid-Lidt G., Gonzalez-Hermosillo A. et al. Clinical features and in-hospital mortality associated with different types of atrial fibrillation in patients with acute coronary syndrome with and without ST elevation. Journal of Cardiology. 2015,66 (2):148-54. DOI:10.1016/j. jjcc. 2014.11.001

8. Braga CG, Ramos V., Martins J., Arantes C., Abreu G., Vieira C. et al. Impact of atrial fibrillation type during acute coronary syndromes: Clinical features and prognosis. Revista Portuguesa de Cardiologia. 2015,34 (6):403-10. DOI:10.1016/j. repc. 2015.01.010

9. Руда М.Я., Голицын С. П., Грацианский Н. А., Комаров А. Л., Панченко Е. П., Староверов И. И. и др. Национальные рекомендации по диагностике и лечению больных острым ИМ с подъемом сегмента ST ЭКГ. Кардиоваскулярная терапия и профилактика. 2007,6 (8 S1):415-500.

10. Authors/Task Force Members, Bassand J-P, Hamm CW, Ardissino D., Boersma E., Budaj A. et al. Guidelines for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes: The Task Force for the Diagnosis and Treatment of Non-ST-Segment Elevation Acute Coronary Syndromes of the European Society of Cardiology. European Heart Journal. 2007,28 (13):1598-660. DOI:10.1093/eurheartj/ehm161

11. Anderson JL, Adams CD, Antman EM, Bridges CR, Califf RM, Casey DE et al. ACC/AHA 2007 Guidelines for the Management of Patients With Unstable Angina/Non - ST-Elevation Myocardial Infarction. Journal of the American College of Cardiology. 2007,50 (7):e1-157. DOI:10.1016/j. jacc. 2007.02.013

12. Authors/Task Force Members, Van de Werf F., BaxJ, Betriu A., Blomstrom-Lundqvist C., Crea F. et al. Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation. European Heart Journal. 2008,29 (23):2909-45. DOI:10.1093/eur-heartj/ehn416

13. Antman EM, Anbe DT, Armstrong PW, Bates ER, Green LA, Hand M. et al. ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1999 Guidelines for the Management of Patients with Acute Myocardial Infarction). Circulation. 2004,110 (9):e82-292. PMID:15339869

14. Kushner FG, Hand M., Smith SC, King SB, Anderson JL, Antman EM et al. 2009 Focused Updates: ACC/AHA Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction (Updating the 2004 Guideline and 2007 Focused Update) and ACC/AHA/SCAI Guidelines on Percutaneous Coronary Intervention (Updating the 2005 Guideline and 2007 Focused Update): A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation. 2009,120 (22):2271-306. DOI:10.1161/CIRCULATIONAHA. 109.192663

15. Руда М.Я., Аверков О.В., Панченко Е.П., Явелов И.С. Рекомендации Общества специалистов по неотложной кардиологии. Диагностика и лечение больных c ОКС без подъема сегмента ST ЭКГ. Часть 1. Кардиология. 2017,57 (8):80-100.

16. Руда М.Я., Аверков О.В., Панченко Е.П., Явелов И.С. Рекомендации Общества специалистов по неотложной кардиологии Диагностика и лечение больных c ОКС без подъема сегмента ST ЭКГ. Часть 2. Кардиология. 2017,57 (9):83-96.

17. Chao T-F., Liu C-J, Wang K-L, Lin Y-J, Chang S-L, Lo L-W et al. Should Atrial Fibrillation Patients With 1 Additional Risk Factor of the CHA2DS2-VASc Score (Beyond Sex) Receive Oral Anticoagulation? Journal of the American College of Cardiology. 2015,65 (7):635-42. DOI:10.1016/j. jacc. 2014.11.046

18. Andrea R. The risk of bleeding of triple therapy with vitamin K-antagonists, aspirin and clopidogrel after coronary stent implantation: Facts and questions: The risk of bleeding of triple therapy with vitamin K-antagonists, aspirin and clopidogrel after coronary stent implantation: Facts and questions.Journal of Geriatric Cardiology. 2012,8 (4):207-14. DOI:10.3724/SP. J. 1263.2011.00207

19. Tantry US, Bonello L., Aradi D., Price MJ, Jeong Y-H, Angiolillo DJ et al. Consensus and Update on the Definition of On-Treatment Platelet Reactivity to Adenosine Diphosphate Associated With Ischemia and Bleeding. Journal ofthe American College of Cardiology. 2013,62 (24):2261-73. DOI:10.1016/j. jacc. 2013.07.101

20. Gorst-Rasmussen A., Lip GYH, Bjerregaard Larsen T. Rivaroxaban versus warfarin and dabigatran in atrial fibrillation: comparative effectiveness and safety in Danish routine care: Rivaroxaban Effectiveness and Safety in Denmark. Pharmacoepidemiology and Drug Safety. 2016,25 ( 11 ) : 1236-44. DOI: 10.1002/pds. 4034

21. Lip GYH, Keshishian A., Kamble S., Pan X., MardekianJ, Horblyuk R. et al. Real-world comparison of major bleeding risk among non-valvular atrial fibrillation patients initiated on apixaban, dabigatran, rivaroxaban, or warfarin: A propensity score matched analysis. Thrombosis and Haemostasis. 2016,116 (11):975-86. DOI:10.1160/TH16-05-0403

22. Lip GYH, Frison L., HalperinJL, Lane D.A. Comparative Validation of a Novel Risk Score for Predicting Bleeding Risk in Anticoagulated Patients With Atrial Fibrillation. Journal of the American College of Cardiology. 2011,57 (2):173-80. DOI:10.1016/j. jacc. 2010.09.024

23. Fang MC, Go AS, Chang Y., Borowsky LH, Pomernacki NK, Udaltsova N. et al. A New Risk Scheme to Predict Warfarin-Associated Hemorrhage. Journal of the American College of Cardiology. 2011,58 (4):395-401. DOI:10.1016/j. jacc. 2011.03.031

24. Gage BF, Yan Y., Milligan PE, Waterman AD, Culverhouse R., Rich MW et al. Clinical classification schemes for predicting hemorrhage: Results from the National Registry of Atrial Fibrillation (NRA.F). American Heart Journal. 2006,151 (3):713-9. DOI:10.1016/j. ahj. 2005.04.017

25. Olesen JB, Lip GYH, Hansen PR, Lindhardsen J., Ahlehoff O., Andersson C. et al. Bleeding risk in “real world” patients with atrial fibrillation: comparison of two established bleeding prediction schemes in a nationwide cohort: Prediction of bleeding in AF patients. Journal of Thrombosis and Haemostasis. 2011,9 (8):1460-7. DOI:10.1111/j. 1538-7836.2011.04378. x

26. Apostolakis S., Lane DA, Buller H., Lip GYH. Comparison of the CHADS2, CHA2DS2-VASc and HAS-BLED scores for the prediction of clinically relevant bleeding in anticoagulated patients with atrial fibrillation: The AMADEUS trial. Thrombosis and Haemostasis. 2013,110 (11):1074-9.DOI:10.1160/TH13-07-0552

27. Marcucci M., Lip GYH, Nieuwlaat R., Pisters R., Crijns HJGM, Iorio A. Stroke and Bleeding Risk Co-distribution in Real-world Patients with Atrial Fibrillation: The Euro Heart Survey. The American Journal of Medicine. 2014,127 (10):979-986. e2. DOI:10.1016/j. amjmed. 2014.05.003

28. Mennuni MG, Halperin JL, Bansilal S., Schoos MM, Theodoropoulos KN, Meelu OA et al. Balancing the Risk of Bleeding and Stroke in Patients With Atrial Fibrillation After Percutaneous Coronary Intervention (from the AVIATOR Registry). The American Journal of Cardiology. 2015,116 (1):37-42. DOI:10.1016/j. amjcard. 2015.03.033

29. Friberg L., Rosenqvist M., Lip GYH. Evaluation of risk stratification schemes for ischaemic stroke and bleeding in 182678 patients with atrial fibrillation : the Swedish Atrial Fibrillation cohort study. Eur Heart J. 2012,33 (12):1500-10. DOI:10.1093 / eur-heartj / ehr488

30. Moreva OVM, Kropacheva ESK, DobrovolskyABD, Titaeva EVT, Panchenko EPP, Institute of Cardiology of Russian Cardiology Scientific and Production Complex, Moscow, Russia. Risk Factors of Recurrent Bleedings at Therapeutic International Normalized Ratio in Patients on Long-Term Warfarin Therapy. Kardiologiia. 2016,2_2016:40-6. DOI: 10.18565 /cardio. 2016.2.40-46

31. Halvorsen S., Storey RF, Rocca B., Sibbing D., ten BergJ, Grove EL et al. Management of antithrombotic therapy after bleeding in patients with coronary artery disease and/or atrial fibrillation: expert consensus paper of the European Society of Cardiology Working Group on Thrombosis. European Heart Journal. 2016, ehw454. DOI:10.1093/eur-heartj/ehw454

32. Faxon D., Eikelboom J., Berger P., Holmes D., Bhatt D., Moliterno D. et al. Consensus Document: Antithrombotic therapy in patients with atrial fibrillation undergoing coronary stenting: A North-American perspective. Thrombosis and Haemostasis. 2011,106 (10):571-84. DOI: 10.1160/TH11-04-0262

33. Dewilde WJM, Oirbans T., Verheugt FWA, Kelder JC, De Smet BJGL, Herrman J-P et al. Use of clopidogrel with or without aspirin in patients taking oral anticoagulant therapy and undergoing percutaneous coronary intervention: an open-label, randomised, controlled trial. Lancet. 2013,381 (9872):1107-15. DOI:10.1016/S0140-6736 (12)62177-1